📰 Sclerosis News
Page 8 - Sclerosis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sclerosis. Real-time updates on events, politics, business and more.
June 21, 2021
Should be reviewed. that never ever happened. so everybody that had a transfusion have had transfusions in the at—risk period. and really should be offered test for fc 28 hep c. which is never happened. do should be offered test for fc 28 hep c. which is never happened.- c. which is never happened. do you think our c. which is never happened. do you think your medical— c. which is never happened. do you think your medical prognosis - c. which is never happened. do you think your medical prog...
June 21, 2021
.atno . at no time during my operations did anybody say well actually, youre transfusion was in the at—risk period. we youre transfusion was in the at-risk period.— youre transfusion was in the at-risk period. youre transfusion was in the at-risk eriod. . , ., , at-risk period. we should test you for hep c- — at-risk period. we should test you for hep c- if _ at-risk period. we should test you for hep c. if that _ at-risk period. we should test you for hep c. if that is _ at-risk period. w...
April 2, 2021
Signal detection theory can be used to better understand cognitive fatigue A team of New Jersey researchers has shown that changes in perceptual certainty and response bias, two central metrics of signal detection theory (SDT), correlate with changes in cognitive fatigue. They also show that SDT measures change as a function of changes in brain activation. This finding was reported in Frontiers in Psychology on January 15, 2021, in the open access article "Using Signal Detection Theory to Bett...
April 1, 2021
(0) NEW YORK, NY / ACCESSWIRE / April 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the first patient has been dosed in an open-label Phase 2 clinical trial of belumosudil, the Companys ROCK2 inhibitor, in patients with diffuse cutaneous systemic sclerosis (dcSSc), a chronic immune disorder characterized by fibrosis of the skin and internal organs. The Phase 2 study (KD025-215) will enroll up to 15 adults with dcSSc who will receive orally administered belumosudil 200 mg tw...
March 17, 2021
Sex differences play roles in how patients respond to brain diseases Men and women are impacted differently by brain diseases, like Alzheimers disease and Parkinsons disease. Researchers are urging their colleagues to remember those differences when researching treatments and cures. In APL Bioengineering, by AIP Publishing, University of Maryland scientists highlight a growing body of research suggesting sex differences play roles in how patients respond to brain diseases, as well as multiple s...
March 10, 2021
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
March 10, 2021
Researchers confirm new drug development route for treating multiple sclerosis, asthma Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma. The venomous toadfish Thalassophryne nattereri contains a peptide (TnP) with anti-inflammatory and anti-allergic potential. Confirmation of this potential has now come via the zebrafish Danio rerio, a popular aquarium specie...
March 4, 2021
Researchers identify the trigger of key cellular change in amyotrophic lateral sclerosis Scientists at the Francis Crick Institute and UCL have identified the trigger of a key cellular change in amyotrophic lateral sclerosis (ALS), a type of motor neurons disease. The findings could help develop new treatments for many neurological diseases with the same change, including Parkinsons and Alzheimers. When the nervous system is injured, diseased or infected, star-shaped cells, called astrocytes, u...
February 26, 2021
Experts highlight need to support people with disabilities in post-pandemic workplace COVID-19 has wrought havoc on the global economy and the worlds public health systems. People with disabilities are more likely to suffer severe cases of the disease. Experts advocate in this special issue of the Journal of Vocational Rehabilitation that vocational rehabilitation across the major life phases of health, work, and education must focus on access to technology and home-based employment and ensure...
February 23, 2021
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.